Metlife Inc. buy UBS Group AG
Summary
This prediction ended on 11.01.25 with a price of €77.85. The prediction had a final performance of 23.10%. UBS_Group_AG has a follow-up prediction for Metlife Inc. where he still thinks Metlife Inc. is a Buy. Dividends of €1.99 are taken into consideration when calculating the performance. UBS_Group_AG has 50% into this predictionMetLife Inc. (Symbol: MET) (WKN: 934623) is a globally renowned insurance, annuities, and employee benefits company, founded in 1868, with its headquarters in New York City. As a leading player in the financial services sector, this Fortune 500 company offers a comprehensive range of products and services, including life insurance, dental and vision coverage, accident and health insurance, retirement and savings solutions, and more. Boasting a diverse clientele, MetLife serves individual customers, SMEs, and large-scale corporations across the globe, with a strong focus on enhancing value for its shareholders, policyholders, and clients. With an underlying commitment to innovation and customer-centric strategies, this publicly traded company (NYSA: MET) has established its presence in more than 40 countries, continuing to expand its horizons in the changing dynamics of global demographics and financial security needs.
Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Metlife Inc. | 2.486% | 2.486% | 2.711% |
| iShares Core DAX® | 3.109% | -0.124% | 36.052% |
| iShares Nasdaq 100 | 3.088% | 4.723% | 20.631% |
| iShares Nikkei 225® | 4.760% | 5.051% | 11.016% |
| iShares S&P 500 | 1.840% | 3.430% | 13.790% |
Comments by UBS_Group_AG for this prediction
In the thread Metlife Inc. diskutieren
In the thread Trading Metlife Inc.